Sanofi (SNY) Enterprise Value (2016 - 2025)
Sanofi (SNY) has disclosed Enterprise Value for 11 consecutive years, with -$8.9 billion as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 12.09% to -$8.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.9 billion through Dec 2025, down 12.09% year-over-year, with the annual reading at -$8.7 billion for FY2025, 7.42% down from the prior year.
- Enterprise Value hit -$8.9 billion in Q4 2025 for Sanofi, down from -$8.0 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$8.0 billion in Q4 2024 to a low of -$13.0 billion in Q4 2022.
- Historically, Enterprise Value has averaged -$10.2 billion across 5 years, with a median of -$9.4 billion in 2023.
- Biggest five-year swings in Enterprise Value: soared 30.37% in 2021 and later fell 12.48% in 2022.
- Year by year, Enterprise Value stood at -$11.6 billion in 2021, then dropped by 12.48% to -$13.0 billion in 2022, then grew by 27.88% to -$9.4 billion in 2023, then grew by 15.15% to -$8.0 billion in 2024, then dropped by 12.09% to -$8.9 billion in 2025.
- Business Quant data shows Enterprise Value for SNY at -$8.9 billion in Q4 2025, -$8.0 billion in Q4 2024, and -$9.4 billion in Q4 2023.